Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 54, Issue , 2014, Pages 92-102

  Hou, Yue ^a,b   Xie, Guanbo ^a   Miao, Fengrong ^a   Ding, Lingling ^a   Mou, Yanhua ^a   Wang, Lihui ^a   Su, Guangyue ^a   Chen, Guoliang ^a   Yang, Jingyu ^a   Wu, Chunfu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

Author keywords

Lipopolysaccharide; Memory; Microglia; Neurons; Pterostilbene

Indexed keywords

CELL PROTEIN; DOUBLECORTIN; INTERLEUKIN 6; NEURON SPECIFIC NUCLEAR PROTEIN; NEUROPROTECTIVE AGENT; NITRIC OXIDE; PROTEIN IBA 1; PTEROSTILBENE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; NOOTROPIC AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEARNING DISORDER; MALE; MEMORY DISORDER; MICROGLIA; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; Y-MAZE TEST; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HIPPOCAMPUS; HUMAN; LEARNING DISORDERS; MAZE TEST; MEMORY DISORDERS; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HUMANS; LEARNING DISORDERS; LIPOPOLYSACCHARIDES; MAZE LEARNING; MEMORY DISORDERS; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; RANDOM ALLOCATION; STILBENES;

EID: 84902477797     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.03.015     Document Type: Article

References (70)

1. Aid S., Langenbach R., Bosetti F. Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. J Neuroinflammation 2008, 5:17.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21(3):383-421.
3. Bhavnani B.R. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol 2003, 85(2-5):473-482.
4. Bi X.L., Yang J.Y., Dong Y.X., Wang J.M., Cui Y.H., Ikeshima T., et al. Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int J Immunopharmacol 2005, 5:185-193.
5. Boillée S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52(1):39-59.
6. Bonow R.H., Aïd S., Zhang Y., Becker K.G., Bosetti F. The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice. Pharmacogenomics J 2009, 9(2):116-126.
7. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 2001, 7(12):548-554.
8. Cao Q., Li P., Lu J., Dheen S.T., Kaur C., Ling E.A. Nuclear factor-kappaB/p65 responds to changes in the Notch signaling pathway in murine BV-2 cells and in amoeboid microglia in postnatal rats treated with the gamma-secretase complex blocker DAPT. J Neurosci Res 2010, 88:2701-2714.
9. Chakraborty S., Kaushik D.K., Gupta M., Basu A. Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res 2010, 88:1615-1631.
10. Chang J., Rimando A., Pallas M., Camins A., Porquet D., Reeves J., et al. Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiol Aging 2012, 33(9):2062-2071.
11. Choi Y., Lee M.K., Lim S.Y., Sung S.H., Kim Y.C. Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells. Br J Pharmacol 2009, 156:933-940.
12. Choi D.Y., Lee J.W., Lin G., Lee Y.K., Lee Y.H., Choi I.S., et al. Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway. Neurochem Int 2012, 60(1):68-77.
13. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
14. Doi Y., Mizuno T., Maki Y., Jin S., Mizoguchi H., Ikeyama M., et al. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am J Pathol 2009, 175:2121-2132.
15. Dong J., Zhou M., Wu X., Du M., Wang X. Memantine combined with environmental enrichment improves spatial memory and alleviates Alzheimer's disease-like pathology in senescence-accelerated prone-8 (SAMP8) mice. J Biomed Res 2012, 26:439-447.
16. Galle A.A., Jones N.M. The neuroprotective actions of hypoxic preconditioning and postconditioning in a neonatal rat model of hypoxic-ischemic brain injury. Brain Res 2013, 1498:1-8.
17. Gao H.M., Hong J.S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 2008, 29(8):357-365.
18. Haba R., Shintani N., Onaka Y., Wang H., Takenaga R., Hayata A., et al. Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: possible role of activation of the central amygdale. Behav Brain Res 2012, 228:423-431.
19. Hartmann A., Hunot S., Hirsch E.C. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp Neurol 2003, 184(2):561-564.
20. Hauss-Wegrzyniak B., Lukovic L., Bigaud M., Stoeckel M.E. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res 1998, 794(2):211-224.
21. Hauss-Wegrzyniak B., Lynch M.A., Vraniak P.D., Wenk G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp Neurol 2002, 176(2):336-341.
22. Hensley K. Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 2010, 21:1-14.
23. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008, 28(33):8354-8360.
24. Hou Y., Wu C.F., Yang J.Y., Guo T. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(8):1486-1495.
25. Hou Y., Wu C.F., Yang J.Y., He X., Bi X.L., Yu L., et al. Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(8):1523-1528.
26. Hou Y., Zhang H., Xie G., Cao X., Zhao Y., Liu Y., et al. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice. Prog Neuropsychopharmacol Biol Psychiatry 2013, 45:107-116.
27. Huang H.J., Chen Y.H., Liang K.C., Jheng Y.S., Jhao J.J., Su M.T., et al. Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection. PLoS One 2012, 7(7):e39656.
28. Iwai T., Iinuma Y., Kodani R., Oka J. Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents. Neurosci Res 2008, 61:113-119.
29. Joseph J.A., Fisher D.R., Cheng V., Rimando A.M., Shukitt-Hale B. Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J Agric Food Chem 2008, 56(22):10544-10551.
30. Kahn M.S., Kranjac D., Alonzo C.A., Haase J.H., Cedillos R.O., McLinden K.A., et al. Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse. Behav Brain Res 2012, 229(1):176-184.
31. Kapetanovic I.M., Muzzio M., Huang Z., Thompson T.N., McCormick D.L. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 2011, 68(3):593-601.
32. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 2000, 20(16):6309-6316.
33. Kim J.I., Lee C.J., Jin M.S., Lee C.H., Paik S.G., Lee H., et al. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem 2005, 280:11347-11351.
34. Kim S.E., Ko I.G., Park C.Y., Shin M.S., Kim C.J., Jee Y.S. Treadmill and wheel exercise alleviate lipopolysaccharide-induced short-term memory impairment by enhancing neuronal maturation in rats. Mol Med Rep 2013, 7(1):31-36.
35. Kitazawa M., Oddo S., Yamasaki T.R., Green K.N., LaFerla F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005, 25(39):8843-8853.
36. Lee J.C., Ahn J.H., Lee D.H., Yan B.C., Park J.H., Kim I.H., et al. Neuronal damage and gliosis in the somatosensory cortex induced by various durations of transient cerebral ischemia in gerbils. Brain Res 2013, 1510:78-88.
37. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003, 100(14):8514-8519.
38. Lijia Z., Zhao S., Wang X., Wu C., Yang J. A self-propelling cycle mediated by reactive oxide species and nitric oxide exists in LPS-activated microglia. Neurochem Int 2012, 61(7):1220-1230.
39. Lin H.S., Yue B.D., Ho P.C. Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 2009, 23(12):1308-1315.
40. Liu P., Zou L., Jiao Q., Chi T., Ji X., Qi Y., et al. Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats. Neurosci Lett 2013, 543:115-120.
41. Liu P., Zou L.B., Wang L.H., Jiao Q., Chi T.Y., Ji X.F., et al. Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats. Psychopharmacology (Berl) 2014, 231:345-356.
42. McCormack D., McFadden D. Pterostilbene and cancer: current review. J Surg Res 2012, 173(2):e53-e61.
43. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374(6523):647-650.
44. Meng X.L., Yang J.Y., Chen G.L., Zhang L.J., Wang L.H., Li J., et al. RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. Int Immunopharmacol 2008, 8:1074-1082.
45. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005, 18(3):315-321.
46. Miwa M., Tsuboi M., Noguchi Y., Enokishima A., Nabeshima T., Hiramatsu M. Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2. J Neuroinflammation 2011, 8:153.
47. Morley J.E., Farr S.A., Kumar V.B., Banks W.A. Alzheimer's disease through the eye of a mouse. Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize. Peptides 2002, 23(3):589-599.
48. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11(1):47-60.
49. Mouri A., Noda Y., Shimizu S., Tsujimoto Y., Nabeshima T. The role of cyclophilin D in learning and memory. Hippocampus 2010, 20(2):293-304.
50. Nam K.N., Koketsu M., Lee E.H. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappaB inhibition. Eur J Pharmacol 2008, 589:53-57.
51. Pan M.H., Chang Y.H., Tsai M.L., Lai C.S., Ho S.Y., Badmaev V., et al. Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. J Agric Food Chem 2008, 56(16):7502-7509.
52. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27:119-145.
53. Remsberg C.M., Yáñez J.A., Ohgami Y., Vega-Villa K.R., Rimando A.M., Davies N.M. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res 2008, 22(2):169-179.
54. Rimando A.M., Suh N. Biological/chemopreventive activity of stilbenes and their effect on colon cancer. Planta Med 2008, 74(13):1635-1643.
55. Rogers J., Strohmeyer R., Kovelowski C.J., Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 2002, 40(2):260-269.
56. Roupe K.A., Remsberg C.M., Yáñez J.A., Davies N.M. Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 2006, 1(1):81-101.
57. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl) 1988, 94:491-495.
58. Schwab C., McGeer P.L. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 2008, 13(4):359-369.
59. Schwab J.M., Schluesener H.J. Microglia rules: insights into microglial-neuronal signaling. Cell Death Differ 2004, 11:1245-1246.
60. Tanaka S., Ide M., Shibutani T., Ohtaki H., Numazawa S., Shioda S., et al. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 2006, 83(4):557-566.
61. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995, 13:437-457.
62. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006, 16:296-300.
63. Wang J., Ho L., Zhao Z., Seror I., Humala N., Dickstein D.L., et al. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 2006, 20:2313-2320.
64. Wang Y., Ding L., Wang X., Zhang J., Han W., Feng L., et al. Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells. Am J Transl Res 2012, 4(1):44-51.
65. Wang C.M., Liu M.Y., Wang F., Wei M.J., Wang S., Wu C.F., et al. Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease. Pharmacol Biochem Behav 2013, 106:57-67.
66. Wang X., Hu D., Zhang L., Lian G., Zhao S., Wang C., et al. Gomisin A inhibits lipopolysaccharide-induced inflammatory responses in N9 microglia via blocking the NF-κB/MAPKs pathway. Food Chem Toxicol 2013, 63C:119-127. [Nov 7, Epub ahead of print]. 10.1016/j.fct.2013.10.048.
67. Yan Y., Yang J., Chen G., Mou Y., Zhao Y., Pan L., et al. Protection of resveratrol and its analogues against ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Mutat Res 2011, 721(2):171-177.
68. Zhang L., Wu C., Zhao S., Yuan D., Lian G., Wang X., et al. Demethoxycurcumin, a natural derivative of curcumin attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-kappaB signaling pathways in N9 microglia induced by lipopolysaccharide. Int Immunopharmacol 2010, 10:331-338.
69. Zhao S., Zhang L., Lian G., Wang X., Zhang H., Yao X., et al. Sildenafil attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-κB signaling pathways in N9 microglia. Int Immunopharmacol 2011, 11:468-474.
70. Zhao Y.N., Wang F., Fan Y.X., Ping G.F., Yang J.Y., Wu C.F. Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure. Behav Brain Res 2013, 236:270-282.